Tumour necrosis factor stimulated gene 6 intrinsically regulates PD‐L1 expressions in breast cancer cells, leading to modulation of tumour microenvironment
Veterinary and Comparative Oncology · 2023
DOI: 10.1111/vco.12884 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary and Comparative Oncology, 2023. Verfasst von Jeong-Hwa Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: K-BIO KIURI Center, Seoul National University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Breast Neoplasms, Dog Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Korea Initiative for fostering University of Research and Innovation Program, Korea Initiative for fostering University of Research and Innovation Program of the National Research Foundation.
Abstract (Originalsprache)
Recent studies have shown that tumour cells express tumour necrosis factor‐inducible gene 6 (TSG‐6) and its protein, which is known to play a key role in regulating excessive immune responses and proliferation and growth of mesenchymal stem cells (MSCs). It has not been confirmed whether the inhibition of TSG‐6 for tumour cells can suppress tumour cell growth and regulate the activation of immune cells in the tumour microenvironment (TME). TSG‐6 ‐specific small interfering RNA was transfected into canine and human breast cancer cells (CIPp, CIPm and BT‐20). TSG‐6 ‐down‐regulated (siTSG‐6) cells showed decreased cell proliferation, migration, and invasion abilities. Decreased mRNA expressions of NF‐κB, STAT3 and Sox2, confirming that TSG‐6 is an upper factor governing tumour growth and metastasis. Notably, siTSG‐6 cells showed significantly decreased expression levels of CD44 and PD‐L1. Direct and indirect co‐culture of canine peripheral blood mononuclear cells (cPBMCs) and the siTSG‐6 cells showed significant activation in M1 type macrophages and cytotoxic T cells. They also showed a tendency to decrease in the expression of CTLA‐4 and increase in the expression of PD‐1. In conclusion, this study suggests that the down‐regulation of TSG‐6 in breast cancer cells could not only suppress tumour growth and metastasis, and but also regulate TME. Since modulation of immune checkpoint proteins occurs in both tumour cells and immune cells, inhibiting TSG‐6 and its protein within the TME could be novel therapeutic target for anticancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- K-BIO KIURI Center, Seoul National University, Seoul, Republic of Korea.
- Laboratory of Veterinary Theriogenology, Department of Veterinary Clinical Science, College of Veterinary Medicine, Seoul National University, Seoul, Republic of Korea.
- Laboratory of Veterinary Internal Medicine, Department of Veterinary Clinical Science, College of Veterinary Medicine, Seoul National University, Seoul, Republic of Korea.
- Department of Veterinary Emergency and Critical Care Medicine and Institute of Veterinary Science, College of Veterinary Medicine, Kangwon National University, Chuncheon-si, Republic of Korea.
ORCID-Profile: Jeong-Hwa Lee, Hwa-Young Youn
Förderung
- Korea Initiative for fostering University of Research and Innovation Program
- Korea Initiative for fostering University of Research and Innovation Program of the National Research Foundation
Zitieren
APA
Lee, J. H., An, J. H., & Youn, H. Y. (2023). Tumour necrosis factor stimulated gene 6 intrinsically regulates PD‐L1 expressions in breast cancer cells, leading to modulation of tumour microenvironment. Veterinary and Comparative Oncology. https://doi.org/10.1111/vco.12884
Vancouver
Lee JH, An JH, Youn HY. Tumour necrosis factor stimulated gene 6 intrinsically regulates PD‐L1 expressions in breast cancer cells, leading to modulation of tumour microenvironment. Veterinary and Comparative Oncology. 2023. doi:10.1111/vco.12884
BibTeX
@article{Lee2023,
author = {Lee, Jeong-Hwa and An, Ju-Hyun and Youn, Hwa-Young},
title = {Tumour necrosis factor stimulated gene 6 intrinsically regulates PD‐L1 expressions in breast cancer cells, leading to modulation of tumour microenvironment},
journal = {Veterinary and Comparative Oncology},
year = {2023},
doi = {10.1111/vco.12884}
}
EUVIMED